Clear Scientific receives funding award from NIDA for continued development of opioid antidotes

Cambridge, Massachusetts | February 2022

Opioid use in the context of polysubstance use (i.e., co-use of two or more illicit substances) is common and further exacerbates the problem of treating acute opioid overdose. Clear Scientific Inc. has received a grant from NIDA to develop a broad-spectrum antidote against acute intoxication caused by the most prevalent drugs of abuse.